Text: H.R.568 — 117th Congress (2021-2022)All Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in House (01/28/2021)


117th CONGRESS
1st Session
H. R. 568


To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

January 28, 2021

Mrs. McClain introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act” or the “Safe RESEARCH Act”.

SEC. 2. Prohibition on research with human fetal tissue obtained pursuant to an abortion.

(a) In general.—Section 498A of the Public Health Service Act (42 U.S.C. 289g–1) is amended—

(1) in the section heading, by striking “Research on transplantation of fetal tissue” and inserting “Research with fetal tissue”;

(2) by amending subsection (a) to read as follows:

“(a) Establishment of program.—

“(1) IN GENERAL.—The Secretary may conduct or support research with human fetal tissue, or research on modern, efficient alternatives to human fetal tissue such as organoids, induced pluripotent stem cells, and adult stem cells. The Secretary shall conduct or support any such research in accordance with this section.

“(2) SOURCE OF TISSUE.—Human fetal tissue may be used in research carried out under paragraph (1) only if the tissue is obtained pursuant to a stillbirth.”;

(3) in subsection (b)(2)—

(A) by striking subparagraph (A); and

(B) by redesignating subparagraphs (B) and (C) as subparagraphs (A) and (B), respectively;

(4) in subsection (c)(1)(B), by striking “may have been obtained pursuant to a spontaneous or induced abortion or pursuant to a stillbirth” and inserting “has been obtained pursuant to a stillbirth”;

(5) in subsection (e), by adding at the end the following new paragraph:

“(3) HUMAN FETAL TISSUE OBTAINED FOR RESEARCH.—In research carried out under subsection (a), human fetal tissue may be used only if such tissue was obtained in accordance with applicable State law regulating anatomical gifts.”; and

(6) by amending subsection (g) to read as follows:

“(g) Definitions.—In this section:

“(1) HUMAN FETAL TISSUE.—The term ‘human fetal tissue’ means tissue or cells obtained from a dead human embryo or fetus after a stillbirth.

“(2) STILLBIRTH.—The term ‘stillbirth’ means a fetal death that occurs as a result of natural causes during a pregnancy, including an ectopic pregnancy.”.

(b) Technical amendment.—Paragraph (1) of section 498B(e) of the Public Health Service Act (42 U.S.C. 289g–2(e)(1)) is amended to read as follows:

“(1) The term ‘human fetal tissue’ means tissue or cells obtained from a dead human embryo or fetus after a spontaneous or induced abortion, or after a stillbirth.”.

(c) Revision of regulations.—Not later than one year after the date of the enactment of this Act, the Secretary of Health and Human Services shall revise such regulations as necessary, including section 46.206 of title 45, Code of Federal Regulations, to incorporate the requirements of this section.

(d) Repeal.—Section 113 of the National Institutes of Health Revitalization Act of 1993 (42 U.S.C. 289g–1 note) is hereby repealed.


Share This